The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.
about
4β-Hydroxycholesterol level significantly correlates with steady-state serum concentration of the CYP3A4 substrate quetiapine in psychiatric patients.Pretransplant 4β-hydroxycholesterol does not predict tacrolimus exposure or dose requirements during the first days after kidney transplantation.Response to: 'Response to: Bodyweight-adjustments introduce significant correlations between CYP3A metrics and tacrolimus clearance'.Elevated 4β-hydroxycholesterol/cholesterol ratio in anorexia nervosa patients
P2860
The CYP3A biomarker 4β-hydroxycholesterol does not improve tacrolimus dose predictions early after kidney transplantation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
The CYP3A biomarker 4β-hydroxy ...... after kidney transplantation.
@en
type
label
The CYP3A biomarker 4β-hydroxy ...... after kidney transplantation.
@en
prefLabel
The CYP3A biomarker 4β-hydroxy ...... after kidney transplantation.
@en
P2093
P2860
P50
P356
P1476
The CYP3A biomarker 4β-hydroxy ...... y after kidney transplantation
@en
P2093
Elisabet Størset
Espen Molden
Stein Bergan
P2860
P304
P356
10.1111/BCP.13248
P407
P577
2017-02-27T00:00:00Z